These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 32100117)

  • 1. Batten disease and perioperative complications: a retrospective descriptive study.
    Yamaguchi Y; Lyman R; De Los Reyes E; Kim SS; Uffman JC; Tobias JD
    J Anesth; 2020 Jun; 34(3):342-347. PubMed ID: 32100117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Children with infantile neuronal ceroid lipofuscinosis have an increased risk of hypothermia and bradycardia during anesthesia.
    Miao N; Levin SW; Baker EH; Caruso RC; Zhang Z; Gropman A; Koziol D; Wesley R; Mukherjee AB; Quezado ZM
    Anesth Analg; 2009 Aug; 109(2):372-8. PubMed ID: 19608805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perioperative care of a patient with neuronal ceroid lipofuscinoses.
    Kako H; Martin DP; Tobias JD
    Saudi J Anaesth; 2013 Jul; 7(3):336-40. PubMed ID: 24015141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of neuronal ceroid lipofuscinosis (Batten disease) by electron microscopy in peripheral blood specimens.
    Anderson GW; Smith VV; Brooke I; Malone M; Sebire NJ
    Ultrastruct Pathol; 2006; 30(5):373-8. PubMed ID: 17090516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BATTEN DISEASE CAUSED BY A NOVEL MUTATION IN THE PPT1 GENE.
    Metelitsina TI; Waggoner DJ; Grassi MA
    Retin Cases Brief Rep; 2016; 10(3):211-3. PubMed ID: 26510000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paroxysmal sympathetic hyperactivity in Juvenile neuronal ceroid lipofuscinosis (Batten disease).
    Ostergaard JR
    Auton Neurosci; 2018 Nov; 214():15-18. PubMed ID: 30072301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Funding resources for rare disease research.
    Stehr F; Forkel M
    Biochim Biophys Acta; 2013 Nov; 1832(11):1910-2. PubMed ID: 23608548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experience, knowledge, and opinions about childhood genetic testing in Batten disease.
    Adams HR; Rose K; Augustine EF; Kwon JM; deBlieck EA; Marshall FJ; Vierhile A; Mink JW; Nance MA
    Mol Genet Metab; 2014 Feb; 111(2):197-202. PubMed ID: 24246680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac involvement in juvenile neuronal ceroid lipofuscinosis (Batten disease).
    Ostergaard JR; Rasmussen TB; Mølgaard H
    Neurology; 2011 Apr; 76(14):1245-51. PubMed ID: 21464428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hippocampal volumes in juvenile neuronal ceroid lipofuscinosis: a longitudinal magnetic resonance imaging study.
    Tokola AM; Salli EK; Åberg LE; Autti TH
    Pediatr Neurol; 2014 Feb; 50(2):158-63. PubMed ID: 24411222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The neuronal ceroid-lipofuscinoses: a historical introduction.
    Haltia M; Goebel HH
    Biochim Biophys Acta; 2013 Nov; 1832(11):1795-800. PubMed ID: 22959893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and potential efficacy of gemfibrozil as a supportive treatment for children with late infantile neuronal ceroid lipofuscinosis and other lipid storage disorders.
    Kim K; Kleinman HK; Lee HJ; Pahan K
    Orphanet J Rare Dis; 2017 Jun; 12(1):113. PubMed ID: 28623936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carrier detection of Batten disease (juvenile neuronal ceroid-lipofuscinosis).
    Taschner PE; de Vos N; Post JG; Meijers-Heijboer EJ; Hofman I; Loonen MC; Pinckers AJ; Bleeker-Wagemakers EM; Gardiner RM; Breuning MH
    Am J Med Genet; 1995 Jun; 57(2):333-7. PubMed ID: 7668358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infantile neuronal ceroid-lipofuscinosis is not an allelic form of Batten disease: exclusion of chromosome 16 region with linkage analyses.
    Jokiaho I; Puhakka L; Santavuori P; Manninen T; Nyman K; Peltonen L
    Genomics; 1990 Oct; 8(2):391-3. PubMed ID: 2249855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuronal ceroid lipofuscinosis in The Netherlands-II.
    Pinckers A
    Doc Ophthalmol; 1983 Dec; 56(1-2):143-5. PubMed ID: 6662001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profound infantile neuroretinal dysfunction in a heterozygote for the CLN3 genetic defect.
    de los Reyes E; Dyken PR; Phillips P; Brodsky M; Bates S; Glasier C; Mrak RE
    J Child Neurol; 2004 Jan; 19(1):42-6. PubMed ID: 15032383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are children with Angelman syndrome at high risk for anesthetic complications?
    Landsman IS; Mitzel HM; Peters SU; Bichell TJ
    Paediatr Anaesth; 2012 Mar; 22(3):263-7. PubMed ID: 21801274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation of a novel gene underlying Batten disease, CLN3. The International Batten Disease Consortium.
    Cell; 1995 Sep; 82(6):949-57. PubMed ID: 7553855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients with single ventricle physiology undergoing noncardiac surgery are at high risk for adverse events.
    Brown ML; DiNardo JA; Odegard KC
    Paediatr Anaesth; 2015 Aug; 25(8):846-851. PubMed ID: 25970232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valproate-induced hyperammonemia in juvenile ceroid lipofuscinosis (Batten disease).
    Larsen EP; Ostergaard JR
    Seizure; 2014 Jun; 23(6):429-34. PubMed ID: 24647346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.